Journal of Aerosol Medicine and Pulmonary Drug Delivery

SJR Rank #12,413H-index: 89SJR: 0.476Best quartile: Q2
Publisher

Mary Ann Liebert Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmaceutical ScienceQ2
  • Pharmacology (medical)Q3
  • Pulmonary and Respiratory MedicineQ3

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Inhalation and Respiratory Drug DeliveryAsthma and respiratory diseasesCystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) ResearchNeonatal Respiratory Health ResearchRespiratory Support and MechanismsAdvanced Drug Delivery SystemsNosocomial Infections in ICUAdvancements in Transdermal Drug DeliveryAir Quality and Health Impacts

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

20222025015304560

Detailed Information

ISSN

1941-2703, 1941-2711

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.37

References per Document

37.21

Coverage

2008-2026

Scope

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient. Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes: Pulmonary drug delivery Airway reactivity and asthma treatment Inhalation of particles and gases in the respiratory tract Toxic effects of inhaled agents Aerosols as tools for studying basic physiologic phenomena.

Metrics from SCImago Journal Rank 2025. View on SCImago